Skip to main content

Oncomfort strengthens its commercial organisation Wavre – 2023-02-08

Wavre, February 3, 2023 – Oncomfort SA, the leader in Digital SedationTM for relieving patients’  pain and anxiety while reducing medication, is pleased to announce the appointment of two  new senior team members team, Aymeric Harmant as Chief Commercial Officer and Corina  Cucuruzac as Global Sales Director. 
With these appointments, Oncomfort brings on board experienced leadership to guide the  organisation in its global expansion and the implementation of the company’s strategy in the  development of Digital Sedation™. 

Oncomfort, the Belgian start-up creator of Digital SedationTM, a medical device for relieving  patients’ pain and anxiety using clinically proven therapeutic sessions in Virtual Reality,  announces the appointment of Aymeric Harmant as Chief Commercial Officer and Corina  Cucuruzac as Sales Director, effective on December 12th, 2022.  
As Chief Commercial Officer, Aymeric Harmant will be overseeing the Sales, Marketing and Market  access activities. With over 20 years experience in Medical technologies, Aymeric has held several  leadership positions in sales management, marketing, market access at multiple medical device  companies such as Alaris Medical (now Becton-Dickinson), Guidant (now Abbott/Boston  Scientific), Johnson & Johnson and IBA where he excelled at Go-to-Market strategies and Implementation. Aymeric holds a Master of Biomedical Engineering from the University of Liège  and a Master of Business Administration from the University of Chicago. 

In her position of International Sales Director, Corina will be responsible for the achievement of  sales targets for the company and manage the commercial resources to effectively build and  support the Oncomfort Digital Sedation™ solution. This includes overseeing and leading the  identification of business opportunities, realigning our collaboration with our international partners, building and fostering client relationships, and ensuring the effective sales of the  Oncomfort products to exceed sales forecasts and goals across our current and future new  markets. Over the last past 20 years Corina has accumulated an impressive and successful  experience in organizing and managing direct sales forces, setting up and managing distributors  networks covering up to 30 countries around the globe chiefly during her 14 years tenure at  Terumo Europe. Lately Corina developed her knowledge in the field of oncology at the company  OncoDNA.  

We welcome Corina and Aymeric to the Oncomfort Team and wish them lots of success!


Corina Cucuruza & Aymeric Harmant